New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:24 EDTSQNM, AETSequenom could benefit meaningfully from Aetna decision, says Oppenheimer
After Aetna (AET) recommended measuring cell-free fetal nucleic acids when testing for Down's syndrome in at-risk women, Oppenheimer thinks the recommendation suggests that Aetna is likely to pick up coverage of Sequenom's MaterniT21. The firm reiterates an Outperform rating on Sequenom.
News For SQNM;AET From The Last 14 Days
Check below for free stories on SQNM;AET the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
11:57 EDTSQNMSequenom management to meet with Maxim
Meetings to be held in New York on September 22 with a group luncheon also and in Boston on September 23 hosted by Maxim.
September 16, 2014
10:44 EDTSQNMSequenom lost Inter Partes Review to Ariosa, says Piper Jaffray
Subscribe for More Information
September 9, 2014
07:54 EDTAETAetna reaffirms FY14 operating EPS outlook $6.45, consensus $6.58
Subscribe for More Information
September 8, 2014
07:26 EDTAETMorgan Stanley to hold a conference
Subscribe for More Information
September 4, 2014
12:49 EDTAETJudges to revisit ObamaCare subsidies decision, The Hill reports
Subscribe for More Information
September 3, 2014
14:55 EDTAETObamaCare business exchange to launch in 5 states next month, The Hill says
Subscribe for More Information
06:34 EDTAETNext Obamacare enrollment period may be very difficult, NY Times says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use